MedPath

正大青春宝药业有限公司

Ownership
-
Established
1992-11-06
Employees
-
Market Cap
-
Website
https://qingchunbao.jd.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

124

NMPA:124

Drug Approvals

Fluconazole and Sodium Chloride Injection

Product Name
氟康唑氯化钠注射液
Approval Number
国药准字H20094114
Approval Date
Sep 5, 2024
NMPA

艾叶油软胶囊

Approval Number
国药准字Z20093515
Approval Date
Feb 6, 2024
NMPA

Isosorbide Mononitrate Injection

Product Name
单硝酸异山梨酯注射液
Approval Number
国药准字H20093327
Approval Date
Nov 21, 2023
NMPA

Metoprolol Tartrate Injection

Product Name
酒石酸美托洛尔注射液
Approval Number
国药准字H20093328
Approval Date
Nov 21, 2023
NMPA

Fudosteine Granules

Product Name
福多司坦颗粒
Approval Number
国药准字H20080684
Approval Date
May 23, 2023
NMPA

Fudosteine Tablets

Product Name
福多司坦片
Approval Number
国药准字H20080636
Approval Date
May 15, 2023
NMPA

Fudosteine Capsules

Product Name
福多司坦胶囊
Approval Number
国药准字H20080698
Approval Date
May 15, 2023
NMPA

Mitiglinide Calcium Hydrate Tablets

Product Name
米格列奈钙片
Approval Number
国药准字H20120121
Approval Date
Aug 25, 2022
NMPA

Mitiglinide Calcium Hydrate Tablets

Product Name
米格列奈钙片
Approval Number
国药准字H20120120
Approval Date
Aug 25, 2022
NMPA

Azelnidipine Capsules

Product Name
平之乐
Approval Number
国药准字H20120057
Approval Date
Jul 13, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.